#
Fulcrum Acquires Rights to a Potential Disease-Modifying Therapy for FSHD
Apr 23, 2019
Fulcrum Therapeutics today announced an exclusive worldwide license agreement with GlaxoSmithKline for development and commercialization of the investigational drug losmapimod.
#
GiveBIG 2019
Apr 17, 2019
All 2019 GiveBIG donations will be earmarked for the training of clinical evaluators for future FSHD drug trials.
#
New FSHD CTRN Quarterly Newsletter
Apr 13, 2019
New quarterly publication for the FSHD Clinical Trial Research Network.
#
Progress Update: Understanding the initiation and progression of FSHD-1
Apr 13, 2019
Dr. Pakula provides an update on her research.
#
Progress Update: MRI measurement to identify disease initiation in FSHD
Apr 3, 2019
Prof. Dr. Arend Heerschap provides an update on his research to determine in which muscles and where in a muscle DUX4 starts to be harmful.
#
New Grant Funding
Apr 2, 2019
$350,000 in new grants recently funded.
#
The ReSolve Study Video
Apr 1, 2019
Video by Dr. Leo Wang about the ReSolve Study - Clinical Trial Preparedness to Solve Barriers to Drug Development in FSHD.